岳陽林紙(600963.SH)子公司中標大河村國家考古遺址公園項目景觀綠化(一期)工程施工項目
格隆匯12月14日丨岳陽林紙(600963.SH)公佈,公司全資子公司誠通凱勝生態於2020年12月11日收到鄭州新發展置業有限公司簽發的《中標通知書》,根據該中標通知書,誠通凱勝生態為鄭州大河村國家考古遺址公園項目景觀綠化(一期)工程施工中標單位,中標價為人民幣1.99億元。
建設規模和內容:大河村國家考古遺址公園項目位於鄭東新區CBD西北角,連霍高速以南,新龍路以北,中州大道以東,龍源八街以西。項目總佔地面積約1,582,308平方米(合2,373.5畝)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.